Home Celgene Will Buy Drug Developer Receptos for $7.32 Billion
 

Keywords :   


Celgene Will Buy Drug Developer Receptos for $7.32 Billion

2015-07-15 00:23:18| Biotech - Topix.net

Cancer drug maker Celgene says it will buy drug developer Receptos for $7.32 billion cash, gaining a drug Receptos is studying as a treatment for multiple sclerosis and ulcerative colitis. Celgene agreed to pay $232 per share for Receptos, and the companies valued the deal at $7.2 billion excluding Receptos' cash on hand.

Tags: buy drug developer billion

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
19.11Climate change impacts on cattle industry part of UNL study
19.11Sitz Angus praised for 100-plus years of Angus
19.11Enhancing reproductive success in the cow-calf herd
19.11-XX BLACKW 1
19.11 Fender Telecaster Thinline / Surf Green
19.11HG 24.5cm
19.11
19.11
More »